Cargando…
Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
Autores principales: | Larenas-Linnemann, Désirée Erlinda, Epstein, Tolly, Ponda, Punita, Bernstein, David, Williams, Paul, Creticos, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368643/ https://www.ncbi.nlm.nih.gov/pubmed/32693206 http://dx.doi.org/10.1016/j.anai.2020.07.015 |
Ejemplares similares
-
198 AAAAI Survey on Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment after Missed Doses and Duration of Immunotherapy
por: Linnemann, Désirée Larenas, et al.
Publicado: (2012) -
Allergen immunotherapy: routes, safety, efficacy, and mode of action
por: Hochfelder, Jillian Leigh, et al.
Publicado: (2013) -
Coronavirus disease 2019 and allergen immunotherapy: Theoretical benefits invite to adjustments in practice recommendations
por: Larenas-Linnemann, Désirée, et al.
Publicado: (2020) -
Allergen immunotherapy: past, present and future
por: Durham, Stephen R., et al.
Publicado: (2022) -
Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
por: Morais-Almeida, Mário, et al.
Publicado: (2016)